Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Tunis Med ; 102(4): 217-222, 2024 Apr 05.
Article in English | MEDLINE | ID: mdl-38746961

ABSTRACT

INTRODUCTION: Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact. AIM: determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults. METHODS: In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were investigated using a standard protocol: biological tests, brain imaging, carotid ultrasound and cardiac assessment. Additional investigations were carried out at the discretion of the treating physician. The cause of ischemic stroke was classified according to the TOAST criteria. RESULTS: We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1/4 patients. A definite cause of stroke was identified in 120 patients. Cardio-embolic causes were the most common among our patients (19%) followed by atherosclerosis of the large arteries (11.5%). Other determined etiologies were found in 27.5% of patients. The etiology remained unclear in 40% of cases: undetermined despite complete investigation in 17.5%, undetermined and incompletely investigated 14.5 % and more than one potential pathomechanisms in 8%. CONCLUSION: Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early age. Rheumatic heart diseases remain a frequent cause of AIS in our area.


Subject(s)
Ischemic Stroke , Humans , Tunisia/epidemiology , Adult , Male , Ischemic Stroke/epidemiology , Ischemic Stroke/etiology , Ischemic Stroke/diagnosis , Female , Middle Aged , Young Adult , Retrospective Studies , Risk Factors , Adolescent , Brain Ischemia/epidemiology , Brain Ischemia/etiology , Brain Ischemia/diagnosis
2.
Pharmaceuticals (Basel) ; 16(4)2023 Apr 01.
Article in English | MEDLINE | ID: mdl-37111286

ABSTRACT

This study aimed to evaluate the potentiality of a mineral and antioxidant-rich methanolic extract of the red marine alga Falkenbergia rufolanosa (FRE) against methyl-thiophanate (MT)-induced toxicity in adult rats. The animals were allocated into four groups: controls, MT (300 mg/kg), MT + FRE, and FRE-treated group for 7 days. Our results demonstrated severe mineral perturbations due to MT treatment, especially in calcium and phosphorus levels in plasma, urine, and bone. Similarly, the hematological analysis revealed increased red blood cells, platelets, and white blood cells associated with striking genotoxicity. Interestingly, a significant rise in lipid peroxidation and advanced oxidation protein products level in erythrocytes and bone were noted. Meanwhile, a depletion of the antioxidant status in both tissues occurred. These biochemical alterations were in harmony with DNA degradation and histological variation in bone and blood. In the other trend, data showed that treatment with alga improved MT-induced hematotoxicity, genotoxicity, and oxidative stress in the blood and bone. Osteo-mineral metabolism and bone histo-architecture were also noted. In conclusion, these findings demonstrated that the red alga Falkenbergia rufolanosa is a potent source of antioxidant and antibacterial agents, as revealed by the in vitro analysis.

3.
Blood Coagul Fibrinolysis ; 33(7): 418-421, 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-35867935

ABSTRACT

Hemophilia is a rare constitutional hemorrhagic disorder. There is insufficient epidemiological data on hemophilia in Tunisia. To describe the epidemiological, clinical, therapeutic, and outcome of a cohort of patients with hemophilia in southern Tunisia. A retrospective study was conducted on patients with hemophilia at the Hemophilia Treatment Center of Southern Tunisia in Sfax over 38 years (from January 1982 to December 2020). Data were collected in a regional hemophilia registry of the South Tunisian center. We collected 141 cases of hemophilia, 85% of whom had hemophilia A and 15% had hemophilia B. The severe form represented 65%, followed by the moderate form at 25%. The prevalence of hemophilia was 4.4 in 100 000 population. Family history of hemophilia was found in 70%. The mean age of patients at diagnosis was 28 months. Hemophilia was detected in 87% of cases after hemorrhagic syndrome. Bleeding occurred mainly in hemarthrosis (73%), hematoma (70%), and visceral bleeding (28%). Intracranial bleeding occurred in 6% of cases. Thirty-six percent of patients were on prophylactic therapy. Hemophilic arthropathy was the most important orthopedic complication in our patients (38%). Inhibitory antibodies occurred in 16% of PWH. Transfusion-transmitted infections with HIV and hepatitis C were in 2 and 31% of cases, respectively. The prevalence of hemophilia is still underestimated in our center. The severe form of hemophilia is the most frequent. Hemophilic arthropathy was the most important complication in our patients. This showed that hemophilia is still a disabling disease in our country.


Subject(s)
Hemophilia A , Hemophilia B , Child, Preschool , Hemarthrosis/etiology , Hemophilia A/complications , Hemophilia A/epidemiology , Hemophilia B/complications , Hemophilia B/epidemiology , Hemorrhage/complications , Hemorrhage/etiology , Humans , Retrospective Studies , Tunisia/epidemiology
5.
J Thromb Haemost ; 19(10): 2596-2604, 2021 10.
Article in English | MEDLINE | ID: mdl-34241942

ABSTRACT

BACKGROUND: The involvement of traditional risk factors and combined genetic markers of recurrent arterial ischemic stroke (AIS) in adults remains unclear. OBJECTIVE: This study aims to determine significant clinical and genetic factors of AIS recurrence, and to investigate the combined effect of genotypes on the occurrence of a second cerebral ischemic attack. METHODS: We investigated a cohort study of AIS patients (18-50 years old) followed in the neurology department over 5 years. Traditional and genetic risk factors were carried through a multivariable logistic regression model. We used a Cox proportional hazard model for identifying predictors of recurrence. RESULTS: Two hundred and seventy patients were enrolled in our study. The risk of AIS recurrence was 36.2% within 5 years. The potential risk of recurrence of AIS increased with traditional and genetic risk factors such as hypertension, diabetes mellitus, heart failure, and family history of cerebrovascular diseases. This risk increased with increasing number of genetic factors. The hazard ratio (HR) was 0.66 (95% confidence interval [CI] 0.97-2.67) for the subject with one genetic factor, 1.61 (95% CI 0.97-2.25) for combined methylenetetrahydrofolate reductase (MTHFR) polymorphisms, and 2.57 (95% CI 1.32-4.99) for combined factor V Leiden (FVL) and MTHFR polymorphisms (677 or 1298). The HR for the three polymorphisms combined was 6.04 (95% CI 2.40-15.16). CONCLUSIONS: Our findings suggest that cumulative effect of both traditional and common genetic risk factors was associated with recurrence of ischemic stroke. We demonstrated for the first time that a combined genotype FVL/MTHFR profile increase the risk of a second cerebral ischemic attack.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Adolescent , Adult , Brain Ischemia/diagnosis , Brain Ischemia/genetics , Cohort Studies , Genetic Markers , Humans , Middle Aged , Recurrence , Risk Factors , Stroke/diagnosis , Stroke/genetics , Young Adult
6.
Front Neurosci ; 14: 39, 2020.
Article in English | MEDLINE | ID: mdl-32082112

ABSTRACT

INTRODUCTION: Modern imaging techniques such as blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) allow the non-invasive and indirect measurement of brain activity. Whether changes in signal intensity can be detected in small brainstem regions during a cold pressor test (CPT) has not been explored thoroughly. The aim of this study was to measure whole brain and brainstem BOLD signal intensity changes in response to a modified CPT. METHODS: BOLD fMRI was measured in healthy normotensive participants during a randomized crossover study (modified CPT vs. control test) using ultra-high field 7 Tesla MRI scanner. Data were analyzed using Statistical Parametric Mapping (SPM) in a whole-brain approach, and with a brainstem-specific analysis using the spatially unbiased infra-tentorial template (SUIT) toolbox. Blood pressure (BP) and hormonal responses (norepinephrine and epinephrine levels) were also measured. Paired t-test statistics were used to compare conditions. RESULTS: Eleven participants (six women, mean age 28 ± 8.9 years) were analyzed. Mean arterial BP increased from 83 ± 12 mm Hg to 87 ± 12 mm Hg (p = 0.0009) during the CPT. Whole-brain analysis revealed significant activations linked to the CPT in the right supplementary motor cortex, midcingulate (bilateral) and the right anterior insular cortex. The brainstem-specific analysis showed significant activations in the dorsal medulla. CONCLUSION: Changes in BOLD fMRI signal intensity in brainstem regions during a CPT can be detected, and show an increased response during a cold stress in healthy volunteers. Consequently, BOLD fMRI at 7T is a promising tool to explore and acquire new insights in the comprehension of neurogenic hypertension.

7.
J Hypertens ; 35(10): 2044-2052, 2017 10.
Article in English | MEDLINE | ID: mdl-28562422

ABSTRACT

BACKGROUND: Arterial calcifications increase arterial stiffness and are associated with a faster decline of kidney function in patients with arterial hypertension (AH) and/or chronic kidney disease (CKD). Yet the underlying mechanisms linking arterial calcifications, vascular stiffness and renal function decline are incompletely understood. A novel in-vitro blood test evaluates the propensity of patient's serum to prevent the formation of calcifications by measuring the maturation time of calciprotein particles (CPP) [transformation time of amorphous calcium phosphate-containing primary CPP to crystalline hydroxyapatite-containing secondary CPP (T50)]. We hypothesized that a high arterial stiffness and a high propensity to calcify may be associated with high renal vascular resistance and low renal tissue oxygenation. METHODS: T50 was measured in patients with AH and a preserved renal function, in CKD patients and in healthy controls, a lower T50 indicating a higher risk of calcification. Pulse wave velocity (PWV) was assessed as a measure of arterial stiffness, and renal resistive index was measured by renal Doppler ultrasound. Renal tissue oxygenation was measured by blood oxygenation level-dependent MRI using the mean R2 values of the cortex, the medulla and layers of renal parenchyma. A high R2 value corresponds to a low tissue oxygenation. RESULTS: Mean T50 was 246 ±â€Š129 min in 58 CKD patients, 275 ±â€Š111 min in 48 AH patients and 324 ±â€Š96 min in 39 healthy controls (Panova = 0.008). In multivariable adjusted linear regression analysis, serum T50 correlated negatively with circulating calcium and phosphate levels, mean cortical and medullary R2, PWV, renal resistive index and being hypertensive. PWV was positively associated with R2 levels of outer and inner layers of renal parenchyma. CONCLUSION: The current study shows that hypertensive patients with preserved renal function as well as CKD patients have a higher risk of calcification than controls. High arterial stiffness and calcification propensity are linked to low renal tissue oxygenation and perfusion in hypertensive and CKD patients. These results provide new insights on the relationships among arterial stiffness, renal tissue oxygenation and the risk of developing CKD.


Subject(s)
Hypertension , Kidney/physiopathology , Renal Insufficiency, Chronic , Vascular Calcification , Cohort Studies , Humans , Hypertension/complications , Hypertension/epidemiology , Hypertension/physiopathology , Pulse Wave Analysis , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/physiopathology , Vascular Calcification/complications , Vascular Calcification/epidemiology , Vascular Calcification/physiopathology
8.
Rev Med Suisse ; 12(500): 44-8, 2016 Jan 13.
Article in French | MEDLINE | ID: mdl-26946703

ABSTRACT

In this short review, we present 4 studies published in 2014-2015 which appear to important for clinicians. The results of the SPRINT trial are challenging the target systolic blood pressure (BP) to be achieved in non-diabetic hypertensive. It shows that a target BP <120 mmHg provides clear mortality and morbidity advantages over a <140 mmHg target. The PATHWAY2 and 3 studies reemphasize the important role of potassium sparing diuretics in patients with resistant hypertension and in patients with metabolic syndrome. At last the DENERHTN study conducted in France suggests that renal denervation is not dead and that additional studies are needed to position this technique in management of resistant hypertension.


Subject(s)
Antihypertensive Agents/therapeutic use , Blood Pressure/drug effects , Hypertension/therapy , Denervation/methods , Diuretics, Potassium Sparing/therapeutic use , Humans , Metabolic Syndrome/drug therapy
9.
Rev Med Suisse ; 12(530): 1507-1512, 2016 Sep 14.
Article in French | MEDLINE | ID: mdl-28677924

ABSTRACT

Several important public health issues such as cardiovascular events are resulting from the actual levels of pollution. There are many sources of pollution ; the most common are loud noise, ambient temperature changes and air pollution. In this article, we try to bring out the impact of these factors on blood pressure, which is probably one of the mechanisms implicated in the upsurge of cardiovascular diseases and mortality.


La pollution est responsable de nombreux problèmes de santé publique de grande importance, dont la survenue d'événements cardiovasculaires. Différentes sources de pollution existent ; le bruit, les changements de température, la pollution de l'air sont les plus connus. Dans cet article, nous essayons de souligner l'effet de ces différents polluants sur la pression artérielle comme l'un des mécanismes potentiels pouvant expliquer l'augmentation de la morbi/mortalité cardiovasculaire associée à la pollution.


Subject(s)
Air Pollution/adverse effects , Cardiovascular Diseases/etiology , Noise/adverse effects , Air Pollutants/adverse effects , Blood Pressure , Cardiovascular Diseases/epidemiology , Humans , Public Health , Temperature
10.
Rev Med Suisse ; 12(530): 1513-1517, 2016 Sep 14.
Article in French | MEDLINE | ID: mdl-28677925

ABSTRACT

Since the use of ambulatory blood pressure monitoring (ABPM) in the beginning of the 70's, our perception of blood pressure based only on office blood pressure has been challenged. Indeed, more specific phenotypes such as white coat hypertension, masked hypertension or different circadian patterns of blood pressure have been described and studied. This has resulted in increased use of ambulatory blood pressure measurements for diagnostic and therapeutic purposes. The main focus of this paper is night-time blood pressure. We review, in a non-systematic way, the diagnostic, the prognostic and therapeutic utility of night-time blood pressure. Finally, studies in which antihypertensive drugs are given at night will be presented.


Depuis les années 1970, la mesure ambulatoire de la pression artérielle sur 24 heures a permis d'apporter un regard différent de celui habituellement fixé sur la mesure au cabinet du médecin. Grâce à son emploi, des phénotypes plus spécifiques tels que l'hypertension de la blouse blanche, l'hypertension masquée ou encore les variations circadiennes de la pression artérielle ont été décrits et étudiés, si bien que la prise en charge des patients repose de plus en plus sur cette mesure ambulatoire de la pression artérielle. Dans cet article, nous nous intéresserons à la pression artérielle nocturne. Nous passerons en revue son utilité diagnostique, son pronostic et la thérapeutique. Finalement nous présentons les études avec un traitement antihypertenseur pris spécifiquement le soir.


Subject(s)
Blood Pressure Determination/methods , Blood Pressure/physiology , Hypertension/diagnosis , Antihypertensive Agents/administration & dosage , Blood Pressure Monitoring, Ambulatory/methods , Circadian Rhythm/physiology , Humans , Hypertension/drug therapy , Masked Hypertension/diagnosis , Masked Hypertension/drug therapy , Prognosis , Time Factors , White Coat Hypertension/diagnosis , White Coat Hypertension/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...